DNA vaccination against parasites: hope or mirage?

• Autorzy: Kofta W , Wedrychowicz H.Z.
• Języki publikacji: EN

Abstrakty

EN

Experimental data obtained so far suggest that an efficacious anti-parasitic vaccine must either be completely effective against infective stage of a parasite or it must induce multi-stage, multi-immune response. Recently developed technology of DNA vaccination appears to offer the best prospect for the development of multivalent vaccines that will effectively activate both the humoral and cell mediated mechanisms of the immune system. The strength of the genetic vaccination lays in the continuous expression of the immunogen in the vaccinated organisms. From the evidences gathered so far it appears that the type of immune response elicited by DNA vaccination depends very much on the antigen used and on the way of the vaccine delivery. This paper presents advantages and disadvantages of vaccinating host organism with cDNA encoding for various microbial and parasitic antigens.

Słowa kluczowe

EN

parasitic disease; vaccine delivery; antiparasitic vaccine; infection; immune system; genetic vaccination; animal; helminth; parasite; antigen; DNA vaccination; cDNA encoding; man; multivalent vaccine; immune response

• Wydawca: -
• Czasopismo: Acta Parasitologica
• Rocznik: 1999
• Tom: 44
• Numer: 2
• Opis fizyczny: p.85-92

Twórcy

autor

Kofta W

• Warsaw Agricultural University, Grochowska 272, 03-849 Warsaw, Poland

autor

Wedrychowicz H.Z.

Bibliografia

• Alberti E., Acosta A., Sarmiento M. E., Hidalgo C., Vidal T., Fachado A., Fonte L., Izquierdo L., Infante J. F., Finlay C. M., Sierra G. 1998. Specific cellular and humoral immune response in Balb/c mice immunised with an expression genomic library of Trypanosoma cruzi. Vaccine, 16, 608- 612.
• Anderson R., Gao X.-M., Papakonstantinopoulou A., Fairweather N., Roberts M., Dougan G. 1997. Immunization of mice with DNA encoding fragment C of tetanus toxin. Vaccine, 15, 827-829.
• Ballas Z. K., Rasmussen W. L., Krieg A. M. 1996. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. Journal of Immunology, 157, 1840-1845.
• Ban E. M., van Ginkel F. W., Simecka J. W., Kiyono H., Robinson H. L., McGhee J. R. 1997. Mucosal immunization with DNA encoding influenza hemagglutinin. Vaccine, 15, 811- 813.
• Barnett S. W., Rajasekar S., Legg H., Doe B., Fuller D. H., Haynes J. R., Walker C. M., Steimer K. S. 1997. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit. Vaccine, 15, 869-873.
• Barry M. A., Johnston S. A. 1997. Biological features of genetic immunization. Vaccine, 15, 788-791.
• Chen C. C., Fynan E. F., Robinson H. L., Lu S., Greenberg H. B., Santoro J. C., Herrmann J. E. 1997. Protective immunity induced by rotavirus DNA vaccines. Vaccine, 15, 899-902.
• Cowdery J. S., Chace J. C., Yi A., Krieg A. M. 1996. Bacterial DNA induces NK cells to produce IFN-γ in vivo and increases the toxicity of lipopolysaccharides. Journal of Immunology, 156, 4570-4575.
• Danko I., Wolff J. A. 1994. Direct gene transfer into muscle. Vaccine, 12, 1499-1502.
• Davis H. L., Brazolot Milian C. L., Mancini M., McCluskie M. J., Hadchouel M., Comanita L., Tiollais P., Whalen R. G., Michel M.-L. 1997. DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg- transgenic mice. Vaccine, 15, 849-852.
• DeNoon D. J. 1996. First humans received naked HIV DNA vaccine. AIDS Weekly Plus, August 19, 5-6.
• Donnelly J. J., Friedman A., Ulmer J. B., Liu M. A. 1997. Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination. Vaccine, 15, 865-868.
• Ertl H. C. J., Xiang Z. 1996. Novel vaccine approaches. Journal of Immunology, 156, 3579-3582.
• Fuller D. H., Corb M. M., Barnett S., Steimer K., Haynes J. R. 1997. Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine, 15, 924-925.
• Fynan E., Webster R. G., Fuller D. H., Haynes J. R., Santoro J. C., Robinson H. L. 1993. DNA vaccines: Protective immunizations by parenteral, mucosal and gene-gun inoculations. Proceedings of the National Academy of Sciences of the USA, 90, 11478-11482.
• Gramzinski R. A., Maris D. C., Doolan D., Charoenvit Y., Obaldia N., Rossan R., Sedegah M., Wang R., Hobart P., Margalith M., Hoffman S. 1997. Malaria DNA vaccines in Aotus monkeys. Vaccine, 15, 913-915.
• Graves P., Gelband H., Garner P. 1998. The SPf66 malaria vaccine: what is the evidence for efficacy? Parasitology Today, 14, 218-220.
• Halpern M. D., Kurlander R. J., Pisetsky D. S. 1996. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α. Cellular Immunology, 167, 72-78.
• Harn D. A., Reynolds S. R., Chikunguwo S., Dissayanake S., Skelly P.. Shoemaker C. Okano M. 1998. Peptide and DNA vaccines for schistosomiasis, and discovery of a novel adjuvant that promotes antibody responses. Parasitology International, Suppl., 47, 14.
• Hinkula J.. Lundholm P., Wahren B. 1997. Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses. Vaccine, 15, 874-878.
• Hoffman S. L. 1998a. Phase I malaria DNA vaccine trial yields first data in man. DNA Vaccine Web, Internet, Materials of the Third National Symposium on Basic Aspects of Vaccines.
• Hoffman S. L. 1998b. Use of DNA vaccine technology to overcome obstacles to malaria vaccine development and to utilize data from the malaria genome project. Parasitology International, Suppl., 47, 13.
• Hoffman S. L., Sedegah M., Hedstrom R. C. 1994. Protection against malaria by immunization with a Plasmodium yoelli circumsporozoite protein nucleic acid vaccine. Vaccine, 12, 1529-1533.
• Hoffman S. L., Doolan D. L., Sedegah M., Aguiar J. C., Wang R., Malik A., Gramzinski R. A., Weiss W. R., Hobart P., Norman J. A., Margalith M., Hedstrom R. C. 1997. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use. Vaccine, 15, 842-845.
• Hsu C.-H., Chua K.-Y., Tao M.-H., Huang S.-K., Hsieh K.-H. 1996. Inhibition of specific IgE response in vivo by allergen- gene transfer. International Immunology, 8, 1405-1411.
• Inchauspe G., Major M. E., Nakano I., Vitvitski L., Trepo C. 1997. DNA vaccination for the induction of immune responses against hepatitis C virus proteins. Vaccine, 15, 853-856.
• Johnston S. A., Barry M. A. 1997. Genetic to genomic vaccination. Vaccine, 15, 808-809.
• Jones D. H., Corris S., McDonald S., Clegg J. C. S., Farrar G. H. 1997. Poly (DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine, 15, 814-817.
• Kennedy R. C., Shearer M. H., Hildebrand W. 1997. Nonhuman primate models to evaluate vaccine safety and immunogenicity. Vaccine, 15, 903-908.
• Kim J. K., Ayyavoo V., Bagarazzi M. L., Chattergoon M. A., Boyer J. D.. Wang B., Weiner D. B. 1997a. Development of a multicompetent candidate vaccine for HIV-1. Vaccine, 15, 879-883.
• Kim J. K., Ayyavoo V., Bagarazzi M. L., Chattergoon M. A., Dang K., Wang B., Boyer J. D., Weiner D. B. 1997b. In vivo engineering of a cellular response by coadministration of IL-12 expression vector with a DNA immunogen. Journal of Immunology, 158, 816-826.
• Klavinskis L. S., Gao L., Barnfield C., Lehner T., Parker S. 1997. Mucosal immunization with DNA-liposome complexes. Vaccine, 15, 818-820.
• Klinman D. M., Yi A.-K., Beaucage S. L., Conover J., Krieg A. M. 1996. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proceedings of the National Academy of Sciences of the USA, 93, 2879-2883.
• Leitner W. W., Seguin M. C., Ripley Ballou W., Seitz J. P., Schultz A. M., Sheehy M. J., Lyon J. A. 1997. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. Journal of Immunology, 159, 6112-6119.
• Lewis P. J., Cox G. J. M., van Drunen Littel-van den Hurk S., Babiuk L. A. 1997. Polynucleotide vaccines in animals: enhancing and modulating responses. Vaccine, 15, 861-864.
• Lightowlers M. W. 1994. Vaccination against animal parasites. Veterinary Parasitology, 54, 177-204.
• Liu M. A., McClements W., Ulmer J. B., Shiver J., Donnelly J. 1997. Immunization of non-human primates with DNA vaccines. Vaccine, 15, 909-912.
• Lowrie D. B., Tascon R. E., Colston M. J., Silva C. L. 1994. Towards a DNA vaccine against tuberculosis. Vaccine, 12, 1537-1540.
• Lowrie D. B., Silva C. L., Colston M. J., Ragno S., Tascon R. E. 1997. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine, 15, 834-838.
• Lozes E., Huygen K., Content J., Denis O., Montgomery D. L., Yawman A. M., Vandenbussche P., van Vooren J.-P., Drowart A. M., Ulmer J. B., Liu M. A. 1997. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine, 15, 830-833.
• Lu S., Manson K., Wyand M., Robinson H. L. 1997. SIV DNA vaccine trial in macaques: post-challenge necropsy in vaccine and control groups. Vaccine, 15, 920-923.
• McClements W. L., Armstrong M. E., Keys R. D., Liu M. A. 1997. The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs. Vaccine, 15, 857-860.
• Norman J. A., Hobart P., Manthorpe M., Feigner P., Wheeler C. 1997. Development of improved vectors for DNA-based immunization and other gene therapy applications. Vaccine, 15, 801-803.
• Ockenhouse C. F., Sun P., Lanar D. E., Wellde B. T., Hall B. T., Kester K., Stoute J. A., Magill A., Krzych U., Farley L., Wirtz R. A., Sadoff J. C., Kaslow D. C., Kumar S., Preston Church L. W., Crutcher J. M., Wizel B., Hoffman S., Lalvani A., Hill A. V. S., Tine J. A., Guito K. P., de Taisne C., Anders R., Horii T., Paoletti E., Ripley Ballou W. 1998. Phase I/IIa safety, immunogenicity, and efficacy trial on NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Journal of Infectious Diseases, 177, 1664-1673.
• Pertmer T. M., Eisenbraun M. D., McCabe D., Prayaga S. K., Fuller D. H., Haynes J. R. 1995. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine, 13, 1427-1430.
• Prince A. M., Whalen R., Brotman B. 1997. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine, 15, 916-919.
• Ray N. B., Ewalt L. C., Lodmell D. L. 1997. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection. Vaccine, 15. 892-895.
• Raz E., Tighe H., Sato Y., Corr M., Dudler J. A., Roman M., Swain S. L., Spiegelberg H. L., Carson D. A. 1996. Preferential induction of a Th₁ immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proceedings of the National Academy of Sciences of the USA, 93, 5141-5145.
• Robertson J. S. 1994. Safety considerations for nucleic acid vaccines. Vaccine, 12, 1526-1528.
• Robinson H. L. 1997. Nucleic acid vaccines: an overview. Vaccine, 15, 785-787.
• Sarzotti M., Dean T. A.. Remington M. P., Ly C. D., Furth P A., Robbins D. S. 1997. Induction of cytotoxic T cell responses in newborn mice by DNA immunization. Vaccine, 15, 795- 797.
• Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M.-D., Silverman G. J., Lotz M., Carson D. A., Raz E. 1997. Immunostimulatory DNA sequence necessary for effective intradermal gene immunization. Science, 273, 352-354.
• Schneider J., Gilbert S. C., Blanchard T. J., Hanke T., Robson K. J., Hannan C. M., Becker M., Sinden R., Smith G. L., Hill A. V. 1998. Enhanced immunogenicity for CD8⁺ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Medicine, 4, 397-402.
• Sedegah M., Jones T. R., Kaur M., Hedstrom R., Hobart P., Tine J. A., Hoffman S. L. 1998. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proceedings of the National Academy of Sciences of the USA, 95, 7648-7653.
• Shearer G. M., Clerici M. 1997. Vaccine strategies: selective elicitation of cellular or humoral immunity? Trends in Biotechnology, 15, 106-109.
• Shiver J. W., Davies M.-E., Yasutomi Y., Perry H. C., Freed D. C., Letvin N. L., Liu M. A. 1997. Anti-HIV env immunities elicited by nucleic acid vaccines. Vaccine, 15, 884-887.
• Siegrist C.-A. 1997. Potential advantages and risks of nucleic acid vaccines for infant immunization. Vaccine, 15, 798-800.
• Sizemore D. R., Branstrom A. A., Sadoff J. C. 1997. Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. Vaccine, 15, 804-807.
• Sjolander A., Baldwin T. M., Curtis J. M., Handman E. 1998. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis. Journal of Immunology, 160, 3949-3957.
• Smith H. A., Goldenthal K. L., Vogel F. R., Rabinovich R., Aguado T. 1997. Workshop on the control and standarization of nucleic aęid vaccines. Vaccine, 15, 931-933.
• Tang D., DeVit M., Johnston S. A. 1992. Genetic immunization is a simple method for eliciting an immune response. Nature, 356, 152-154.
• Tine J. A., Lanar D. E., Smith D. M., Wellde B. T., Schultheiss P., Ware L. A., Kauffman E. B., Wirtz R. A., de Taisne C., Hui G. S. N., Chang S. P., Church P., Hollingdale M. R., Kaslow D. C., Hoffman S., Guito K. P., Ripley Ballou W., Sadoff J. C., Paoletti E. 1996. NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Infection and Immunity, 64, 3833-3844.
• Ugen K. E., Boyer J. D., Wang B., Bagarazzi M., Javadian A., Frost P., Merve M. M., Agadjanyan M. G., Nyland S., Wiliams W. V., Coney L., Ciccarelli R., Weiner D. B. 1997. Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial. Vaccine, 15, 927-930.
• Ulmer J. B., Liu M. A., Montgomery D. L., Yawman A. M., Randall Deck R., DeWitt C. M., Content J., Huygen K. 1997a. Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination. Vaccine, 15, 792-794.
• Ulmer J. B., Randall Deck R., DeWitt C. M., Fu T.-M., Donnelly J. J., Caulfield M. J., Liu M. A. 1997b. Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity. Vaccine, 15, 839-841.
• Waine G. J., Yang W., Scott J. C., McManus D. P., Kalinna B. H. 1997. DNA-based vaccination using Schistosoma japonicum (Asian blood-fluke) genes. Vaccine, 15, 846-848.
• Wang B., Dang K., Agadjanyan M. G., Srikantan V., Li F., Ugen K. E., Boyer J., Merva M., Williams W. V., Weiner D. B. 1997. Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site. Vaccine, 15, 821-825.
• Webster R. G., Fynan E. F., Santoro J. C., Robinson H. 1994. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine, 12, 1495-1498.
• Willadsen P. 1995. Commercialisation of a recombinant vaccine against Boophilus microplus. Parasitology, 110, S43-S50.
• Wynn T. A., Cheever A. W., Jankovic D., Poidexter R. W., Caspar P., Lewis F. A., Sher A. 1995. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature, 376, 594-596.
• Xiang Z. Q., He Z., Wang Y., Ertl H. C. J. 1997. The effect of interferon-γ on genetic immunization. Vaccine, 15, 896-898.
• Xu D., Liew F. Y. 1994. Genetic vaccination against leishmaniasis. Vaccine, 12, 1534-1536.
• Xu D., Liew F. Y. 1995. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology, 84, 173-176.
• Xu D., McSorley S. J., Tetley L., Chatfield S., Dougan G., Chan W. L., Satoskar A., David J. R., Liew F. Y. 1998. Protective effect on Leishmania major infection of migration inhibitory factor, TNF-α, and IFN-γ administered orally via attenuated Salmonella typhimurium. Journal of Immunology, 160, 1285-1289.
• Yang W., Waine G. J., McManus D. P. 1995. Antibodies to Schistosoma japonicum (asian bloodfluke) paramyosin induced by nucleic acid vaccination. Biochemical and Biophysical Research Communication, 212, 1029-1039.
• Yang K., Mustafa F., Valsamakis A., Santoro J. C., Griffin D. E., Robinson H. L. 1997. Early studies on DNA-based immunizations for measles virus. Vaccine, 15, 888-892.
• Zimmermann S., Egeter O., Hausmann S., Lipford G. B., Rocken M., Wagner H., Heeg K. 1998. Cutting edge: CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. Journal of Immunology, 160, 3627-3630.